formylmethionyl-leucyl-phenylalanine methyl ester has been researched along with sirolimus in 1 studies
| Studies (formylmethionyl-leucyl-phenylalanine methyl ester) | Trials (formylmethionyl-leucyl-phenylalanine methyl ester) | Recent Studies (post-2010) (formylmethionyl-leucyl-phenylalanine methyl ester) | Studies (sirolimus) | Trials (sirolimus) | Recent Studies (post-2010) (sirolimus) |
|---|---|---|---|---|---|
| 67 | 1 | 6 | 20,711 | 2,368 | 11,516 |
| Protein | Taxonomy | formylmethionyl-leucyl-phenylalanine methyl ester (IC50) | sirolimus (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.25 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 2 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Mus musculus (house mouse) | 0.001 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 4 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0897 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.0042 | |
| Regulatory-associated protein of mTOR | Homo sapiens (human) | 0.225 | |
| Target of rapamycin complex subunit LST8 | Homo sapiens (human) | 0.225 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 1.9 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djerdjouri, B; El-Benna, J; Elkrief, L; Hadjoudj, S; Makhezer, N; Moreau, R; Périanin, A; Rolas, L | 1 |
1 other study(ies) available for formylmethionyl-leucyl-phenylalanine methyl ester and sirolimus
| Article | Year |
|---|---|
Inhibition of mammalian target of rapamycin aggravates the respiratory burst defect of neutrophils from decompensated patients with cirrhosis.
Topics: Antibiotics, Antineoplastic; Cytosol; Drug Interactions; Escherichia coli Infections; Female; HL-60 Cells; Humans; Liver Cirrhosis, Alcoholic; Male; MAP Kinase Signaling System; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophils; p38 Mitogen-Activated Protein Kinases; Phagocytosis; Phosphorylation; Respiratory Burst; Sirolimus; TOR Serine-Threonine Kinases | 2013 |